AVXL peer analysis
Anavex Life Sciences (AVXL) against its competitors: price, today's move, 1-year return and market value side by side.
- AVXL's peers: ABSI (Absci), ARVN (Arvinas), CTMX (CytomX Therapeutics), ERAS (Erasca), MBX (MBX Biosciences), MGTX (MeiraGTx), MLTX (MoonLake Immunotherapeutics), RGNX (REGENXBIO).
AVXL and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABSI Absci | $7.61 | -6.74% | 166.08% | $1.31B |
| ARVN Arvinas | $6.46 | -4.15% | -43.97% | $423.03M |
| CTMX CytomX Therapeutics | $2.04 | -0.34% | -43.72% | $445.41M |
| ERAS Erasca | $13.74 | -3.38% | 397.83% | $4.82B |
| MBX MBX Biosciences | $49.55 | -7.23% | 80.91% | $2.46B |
| MGTX MeiraGTx | $7.98 | -1.97% | 5.28% | $779.89M |
| MLTX MoonLake Immunotherapeutics | $11.07 | 0.36% | -18.24% | $942.13M |
| RGNX REGENXBIO | $7.12 | -0.84% | -34.86% | $470.79M |
| VALN Valneva | $5.37 | 0.47% | -38.33% | $503.46M |
| AVXL Anavex Life Sciences | $0.62 | -7.13% | -82.78% | $57.46M |